Cargando…

Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays

Detalles Bibliográficos
Autores principales:	Tian, Ying, Lian, Chaoyang, Chen, Yingying, Wei, Dong, Zhang, Xinxin, Ling, Yun, Wang, Ying, Yeap, Leng-Siew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589479/ https://www.ncbi.nlm.nih.gov/pubmed/33133635 http://dx.doi.org/10.1038/s41421-020-00224-3

Ejemplares similares

Serological assays for delayed SARS-CoV-2 case identification
por: Choy, Kay Weng
Publicado: (2020)

Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)

The development of neutralizing antibodies against SARS-CoV-2 and their common features
por: Liu, Liu Daisy, et al.
Publicado: (2020)

Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay
por: Isles, Nicole, et al.
Publicado: (2022)

SARS-CoV-2 serological cross-reactivity with autoantibodies
por: Choy, Kay Weng
Publicado: (2021)

Cadaveric donor specimens and serological testing for SARS-CoV-2
por: Yeang, Malinna, et al.
Publicado: (2022)

Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays
por: Osório, Nuno Sampaio, et al.
Publicado: (2021)

Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?
por: Dudreuilh, Caroline, et al.
Publicado: (2020)

SARS-CoV-2 serological cross-reactivity with autoantibodies – Authors' reply
por: Teng, Jialin, et al.
Publicado: (2021)

Challenges in interpreting SARS-CoV-2 serological results in African countries
por: Nkuba Ndaye, Antoine, et al.
Publicado: (2021)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

In Reply to ‘Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?’
por: De Vriese, An S., et al.
Publicado: (2020)

Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection
por: Pallett, Scott J C, et al.
Publicado: (2021)

Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland
por: Perez-Saez, Javier, et al.
Publicado: (2021)

The importance of external quality assessment data in evaluating SARS-CoV-2 virus genome detection assays – Authors‘ reply
por: Au, Wing Ying, et al.
Publicado: (2022)

Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report
por: Lucchini, Matteo, et al.
Publicado: (2020)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

The natural thermal sensitivity of SARS-CoV-2
por: Stewart, Patrick D Shaw, et al.
Publicado: (2022)

Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting
por: Müller, Lisa, et al.
Publicado: (2021)

SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers
por: Hasan, Tasnim, et al.
Publicado: (2021)

SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability
por: Foster, Charles S.P., et al.
Publicado: (2022)

Comparing Nasopharyngeal and BAL SARS-CoV-2 Assays in Respiratory Failure
por: Gao, Catherine A., et al.
Publicado: (2021)

Highly Sensitive and Specific SARS-CoV-2 Serological Assay Using a Magnetic Modulation Biosensing System
por: Avivi-Mintz, Shira, et al.
Publicado: (2021)

Comparison of various serological assays for novel SARS-COV-2
por: Sacristan, María Simón, et al.
Publicado: (2020)

SARS-CoV-2 Multi-Antigen Serology Assay
por: Mazhari, Ramin, et al.
Publicado: (2021)

SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy
por: Ma, Guanqin, et al.
Publicado: (2022)

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
por: Arora, Prerna, et al.
Publicado: (2023)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay
por: Balgahom, Rifky, et al.
Publicado: (2022)

Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
por: Tehrani, Zahra Rikhtegaran, et al.
Publicado: (2020)

Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients
por: Rostamzadeh, Davood, et al.
Publicado: (2021)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Test performance evaluation of SARS-CoV-2 serological assays
por: Whitman, Jeffrey D., et al.
Publicado: (2020)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections
por: Galipeau, Yannick, et al.
Publicado: (2020)

Test performance evaluation of SARS-CoV-2 serological assays
por: Whitman, Jeffrey D., et al.
Publicado: (2020)

Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: James, Joe, et al.
Publicado: (2021)

Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections
por: Luo, Ji, et al.
Publicado: (2022)

Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays
por: Kweon, Oh Joo, et al.
Publicado: (2020)

The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022
por: Ling, Yun, et al.
Publicado: (2022)

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a9pl0jsctbcar8svdmfkp46jin